Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Triple Seven
- Development stage
- Unknown
- Lead developer
- The Cannabist Company
- Modality
- Small Molecules
- Administration
- Inhalation
01
Overview
Triple Seven is a premium cannabis brand developed and marketed by The Cannabist Company (formerly Columbia Care). The brand specializes in high-quality cannabis flower, which is produced through selective breeding and cultivation to achieve specific potency levels and terpene profiles. The primary active constituents in Triple Seven products are cannabinoids, most notably delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). These compounds exert their effects by acting as agonists at the Cannabinoid receptor 1 (CB1) and Cannabinoid receptor 2 (CB2) within the human endocannabinoid system, influencing various physiological processes including pain perception, mood, and appetite. Triple Seven is primarily administered via inhalation and is available in various legal cannabis markets for both medical and adult-use consumers.
- Brand names
- Triple Seven
- Other names
- Triple Seven premium flower
02
Targets
GPR55 (G protein-coupled receptor 55)CNR1 (Cannabinoid receptor 1)
Beyond the preview
Go deeper on Triple Seven.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Triple Seven.